Want to receive publications straight to your inbox?

CATIE
Image

Establishing access to pre-exposure prophylaxis (PrEP) for gay, bisexual and other men who have sex with men (gbMSM) is a key component of HIV prevention strategies because of its proven effectiveness in reducing HIV transmission. Among gbMSM, research has identified chemsex as a factor that can increase risk of HIV. This article summarizes a systemic review and meta-analysis that estimated the global prevalence of PrEP uptake among gbMSM who engage in chemsex and examined whether engagement in chemsex is associated with higher odds of PrEP uptake in this population.

Receive Prevention in Focus in your inbox:

What is chemsex?

Chemsex (also referred to as party and play or PnP) refers to the use of psychoactive substances during sexual activities, primarily among gbMSM. The specific substances used, the sexual activities engaged in, and the reasons for participation can vary depending on the location, the context and the individuals involved. The reasons for participating in chemsex can include increasing feelings of intimacy or connection, libido, sexual arousal, confidence, disinhibition and/or stamina. While there is no consensus on the drugs used during chemsex, the authors highlight methamphetamine, gamma-hydroxybutyrate / gamma-butyrolactone (GHB/GBL) and synthetic cathinones as the substances people most often report using during chemsex.

What kind of information did the systematic review include?

An article was included if it involved HIV-negative adult cisgender gbMSM who self-reported current or past engagement in chemsex and who self-reported whether or not they had used PrEP. The comparator group included adult cisgender gbMSM who self-reported no engagement in chemsex and reported whether or not they were current or past PrEP users.

The review included 28 studies published between 2018 and July 2025. The studies in the review had the following characteristics:

  • All studies were observational and cross-sectional surveys.
  • Fourteen studies were conducted in Western and Central Europe and in North America, 12 studies were conducted in Asia and the Pacific and two studies were conducted in Latin America. 
  • Twenty studies were conducted in high-income countries and eight in low- and middle-income countries.
  • Seventeen studies explicitly mentioned chemsex. Eleven studies referred to chemsex implicitly, in that they reported the use of drugs typically associated with sexual contexts.

The study participants had the following characteristics:

  • Across all of the studies included, there were 36,339 HIV-negative adult cisgender gbMSM participants, of whom 5,690 reported chemsex and 5,881 reported PrEP use.
  • PrEP uptake was self-reported. All studies reported the use of oral tenofovir-based PrEP. One study also referred to long-acting injectable cabotegravir. Studies included daily, on-demand, off-prescription or informal use.

What is the estimated prevalence of PrEP uptake among gbMSM who engage in chemsex?

About 39% of gbMSM who engage in chemsex have used PrEP, on the basis of data combined in this review and meta-analysis from studies around the world. There was no statistically significant difference in this percentage among participants who had recently engaged in chemsex or had ever engaged in chemsex.

Is engagement in chemsex associated with increased odds of PrEP uptake among gbMSM?

Among gbMSM, engagement in chemsex was associated with significantly higher odds of PrEP use compared with those who did not report engaging in chemsex. Overall, those who engaged in chemsex had more than three times the odds of using PrEP (odds ratio [OR] = 3.44). The association was stronger among those who had ever engaged in chemsex (OR = 4.74) than among those who reported recent chemsex (OR = 2.84). Chemsex was associated with PrEP use in all settings, but this association was weaker in low- and middle-income countries than in high-income countries, for both recent and ever engagement in chemsex.

Limitations

The authors note possible small-study effects or publication bias in the analyses estimating the prevalence of PrEP use, particularly in subgroup analyses by timing of chemsex engagement. This suggests that the pooled prevalence estimates should be interpreted with caution.

What are the implications for service providers?

This review shows that gbMSM who engage in chemsex are more likely to use PrEP than those who do not. However, PrEP use varies across this population, and PrEP use alone does not address the full range of health and social needs associated with chemsex.

Service providers play a critical role in helping to increase PrEP uptake. Non-judgmental conversations about PrEP and chemsex are vital, recognizing that a patient’s decisions around disclosure may be shaped by stigma and past healthcare experiences. Providers can support PrEP by actively reducing barriers to care, such as proactively offering PrEP. Building trust, reducing stigma and providing tailored, patient-directed support are central to effective engagement with gbMSM who engage in chemsex. 

While PrEP is highly effective at preventing HIV, it may not address a person’s broader healthcare needs connected to chemsex. Integrated care models that combine clinical sexual health services with harm reduction and mental health supports are better positioned to respond to these intersecting needs, including through referrals to peer-led services, counselling and culturally competent harm reduction services for gbMSM.

What is a systematic review?

Systematic reviews are important tools for informing evidence-based programming. A systematic review is a critical summary of the available evidence on a specific topic. It uses a rigorous process to identify all the studies related to a specific research question. Relevant studies can then be assessed for quality and their results summarized to identify and present key findings and limitations. If studies within a systematic review contain numerical data, these data can be combined in strategic ways to calculate summary (“pooled”) estimates. Combining data to produce pooled estimates can provide a better overall picture of the topic being studied. The process of pooling estimates from different studies is referred to as a meta-analysis.  

Reference

Miñana JG, García SA, De Lazzari E et al. Chemsex and uptake of HIV pre-exposure prophylaxis among adult cisgender gay, bisexual and other men who have sex with men worldwide: a systematic review with meta-analysis. eClinicalMedicine. 2026;93:103804. Available from: https://doi.org/10.1016/j.eclinm.2026.103804

About the author(s)

Caleb Chepesiuk is CATIE's knowledge specialist, harm reduction programming. He has a master of arts degree in legal studies and previously worked in harm reduction service provision.